von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor

Summary The bleeding disorder von Willebrand disease (VWD) is caused by mutations of von Willebrand factor (VWF), a multimeric glycoprotein essential for platelet-dependent primary haemostasis. VWD type 2A–associated mutations each disrupt VWF biosynthesis and function at different stages, depending...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thrombosis and haemostasis 2014, Vol.111 (1), p.96-108
Hauptverfasser: Brehm, Maria A., Huck, Volker, Aponte-Santamaría, Camilo, Obser, Tobias, Grässle, Sandra, Oyen, Florian, Budde, Ulrich, Schneppenheim, Sonja, Baldauf, Carsten, Gräter, Frauke, Schneider, Stefan W., Schneppenheim, Reinhard
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 108
container_issue 1
container_start_page 96
container_title Thrombosis and haemostasis
container_volume 111
creator Brehm, Maria A.
Huck, Volker
Aponte-Santamaría, Camilo
Obser, Tobias
Grässle, Sandra
Oyen, Florian
Budde, Ulrich
Schneppenheim, Sonja
Baldauf, Carsten
Gräter, Frauke
Schneider, Stefan W.
Schneppenheim, Reinhard
description Summary The bleeding disorder von Willebrand disease (VWD) is caused by mutations of von Willebrand factor (VWF), a multimeric glycoprotein essential for platelet-dependent primary haemostasis. VWD type 2A–associated mutations each disrupt VWF biosynthesis and function at different stages, depending on the VWF domain altered by the mutation. These effects cause considerable heterogeneity in phenotypes and symptoms. To characterise the molecular mechanisms underlying the specific VWF deficiencies in VWD 2A/IIC, IID and IIE, we investigated VWF variants with patient-derived mutations either in the VWF pro-peptide or in domains D3 or CK. Additionally to static assays and molecular dynamics (MD) simulations we used microfluidic approaches to perform a detailed investigation of the shear-dependent function of VWD 2A mutants. For each group, we found distinct characteristics in their intracellular localisation visualising specific defects in biosynthesis which are correlated to respective multimer patterns. Using microfluidic assays we further determined shear flow-dependent characteristics in polymer-platelet-aggregate formation, platelet binding and string formation for all mutants. The phenotypes observed under flow conditions were not related to the mutated VWF domain. By MD simulations we further investigated how VWD 2A/IID mutations might alter the ability of VWF to form carboxy-terminal dimers. In conclusion, our study offers a comprehensive picture of shear-dependent and shear-independent dysfunction of VWD type 2A mutants. Furthermore, our microfluidic assay might open new possibilities for diagnosis of new VWD phenotypes and treatment choice for VWD patients with shear-dependent VWF dysfunctions that are currently not detectable by static tests.
doi_str_mv 10.1160/TH13-11-0902
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1160_TH13_11_0902</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>24598842</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-6a136349756b7612eb39dc545b0ddc3ed9033c4dc959f0040f5728b99719394e3</originalsourceid><addsrcrecordid>eNpt0M9LwzAUB_AgipvTm2fJxZOrJs2PNt7GnFoYeJnoraTJK-3oj5F0wsA_3pZNBfGS5D0-5PG-CF1SckupJHerZ8oCSgOiSHiExqGQUSBj9X6MxoRxEsiQixE6835NCJVciVM06lsqjnk4Rp8fbYPfyqqCzOnGYlt60B5wt9sADmd4U0DTDoXHSTKf9scDHlySLO7xDFu9w2WDuwJwVeaA2xz7ArQLfOfAe7C43na66fCfMbk2XevO0UmuKw8Xh3uCXh8Xq_lzsHx5SuazZWB4yLpAasok4yoSMoskDSFjyhrBRUasNQysIowZbo0SKieEk1xEYZwpFVHFFAc2QdP9v8a13jvI040ra-12KSXpEGI6hNi_0iHEnl_t-Wab1WB_8HdqPbg-AO2NrvJ-JVP6XxeLKJIR793N3nVFCTWk63brmn7R_8d-AYCEhWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor</title><source>MEDLINE</source><source>Thieme Connect Journals</source><creator>Brehm, Maria A. ; Huck, Volker ; Aponte-Santamaría, Camilo ; Obser, Tobias ; Grässle, Sandra ; Oyen, Florian ; Budde, Ulrich ; Schneppenheim, Sonja ; Baldauf, Carsten ; Gräter, Frauke ; Schneider, Stefan W. ; Schneppenheim, Reinhard</creator><creatorcontrib>Brehm, Maria A. ; Huck, Volker ; Aponte-Santamaría, Camilo ; Obser, Tobias ; Grässle, Sandra ; Oyen, Florian ; Budde, Ulrich ; Schneppenheim, Sonja ; Baldauf, Carsten ; Gräter, Frauke ; Schneider, Stefan W. ; Schneppenheim, Reinhard</creatorcontrib><description>Summary The bleeding disorder von Willebrand disease (VWD) is caused by mutations of von Willebrand factor (VWF), a multimeric glycoprotein essential for platelet-dependent primary haemostasis. VWD type 2A–associated mutations each disrupt VWF biosynthesis and function at different stages, depending on the VWF domain altered by the mutation. These effects cause considerable heterogeneity in phenotypes and symptoms. To characterise the molecular mechanisms underlying the specific VWF deficiencies in VWD 2A/IIC, IID and IIE, we investigated VWF variants with patient-derived mutations either in the VWF pro-peptide or in domains D3 or CK. Additionally to static assays and molecular dynamics (MD) simulations we used microfluidic approaches to perform a detailed investigation of the shear-dependent function of VWD 2A mutants. For each group, we found distinct characteristics in their intracellular localisation visualising specific defects in biosynthesis which are correlated to respective multimer patterns. Using microfluidic assays we further determined shear flow-dependent characteristics in polymer-platelet-aggregate formation, platelet binding and string formation for all mutants. The phenotypes observed under flow conditions were not related to the mutated VWF domain. By MD simulations we further investigated how VWD 2A/IID mutations might alter the ability of VWF to form carboxy-terminal dimers. In conclusion, our study offers a comprehensive picture of shear-dependent and shear-independent dysfunction of VWD type 2A mutants. Furthermore, our microfluidic assay might open new possibilities for diagnosis of new VWD phenotypes and treatment choice for VWD patients with shear-dependent VWF dysfunctions that are currently not detectable by static tests.</description><identifier>ISSN: 0340-6245</identifier><identifier>EISSN: 2567-689X</identifier><identifier>DOI: 10.1160/TH13-11-0902</identifier><identifier>PMID: 24598842</identifier><identifier>CODEN: THHADQ</identifier><language>eng</language><publisher>Stuttgart: Schattauer GmbH</publisher><subject>Biological and medical sciences ; Blood Coagulation, Fibrinolysis and Cellular Haemostasis ; Blood coagulation. Blood cells ; Blood Platelets - physiology ; Dimerization ; Fundamental and applied biological sciences. Psychology ; HEK293 Cells ; Hematologic and hematopoietic diseases ; Humans ; Medical sciences ; Microfluidics ; Molecular and cellular biology ; Molecular Dynamics Simulation ; Mutation - genetics ; Phenotype ; Platelet diseases and coagulopathies ; Protein Structure, Tertiary - genetics ; Shear Strength - physiology ; von Willebrand Disease, Type 2 - classification ; von Willebrand Disease, Type 2 - genetics ; von Willebrand Factor - genetics ; von Willebrand Factor - metabolism</subject><ispartof>Thrombosis and haemostasis, 2014, Vol.111 (1), p.96-108</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-6a136349756b7612eb39dc545b0ddc3ed9033c4dc959f0040f5728b99719394e3</citedby><cites>FETCH-LOGICAL-c423t-6a136349756b7612eb39dc545b0ddc3ed9033c4dc959f0040f5728b99719394e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.thieme-connect.de/products/ejournals/pdf/10.1160/TH13-11-0902.pdf$$EPDF$$P50$$Gthieme$$H</linktopdf><linktohtml>$$Uhttps://www.thieme-connect.de/products/ejournals/html/10.1160/TH13-11-0902$$EHTML$$P50$$Gthieme$$H</linktohtml><link.rule.ids>314,778,782,3007,4012,27910,27911,27912,54546,54547</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28577674$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24598842$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brehm, Maria A.</creatorcontrib><creatorcontrib>Huck, Volker</creatorcontrib><creatorcontrib>Aponte-Santamaría, Camilo</creatorcontrib><creatorcontrib>Obser, Tobias</creatorcontrib><creatorcontrib>Grässle, Sandra</creatorcontrib><creatorcontrib>Oyen, Florian</creatorcontrib><creatorcontrib>Budde, Ulrich</creatorcontrib><creatorcontrib>Schneppenheim, Sonja</creatorcontrib><creatorcontrib>Baldauf, Carsten</creatorcontrib><creatorcontrib>Gräter, Frauke</creatorcontrib><creatorcontrib>Schneider, Stefan W.</creatorcontrib><creatorcontrib>Schneppenheim, Reinhard</creatorcontrib><title>von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor</title><title>Thrombosis and haemostasis</title><addtitle>Thromb Haemost</addtitle><description>Summary The bleeding disorder von Willebrand disease (VWD) is caused by mutations of von Willebrand factor (VWF), a multimeric glycoprotein essential for platelet-dependent primary haemostasis. VWD type 2A–associated mutations each disrupt VWF biosynthesis and function at different stages, depending on the VWF domain altered by the mutation. These effects cause considerable heterogeneity in phenotypes and symptoms. To characterise the molecular mechanisms underlying the specific VWF deficiencies in VWD 2A/IIC, IID and IIE, we investigated VWF variants with patient-derived mutations either in the VWF pro-peptide or in domains D3 or CK. Additionally to static assays and molecular dynamics (MD) simulations we used microfluidic approaches to perform a detailed investigation of the shear-dependent function of VWD 2A mutants. For each group, we found distinct characteristics in their intracellular localisation visualising specific defects in biosynthesis which are correlated to respective multimer patterns. Using microfluidic assays we further determined shear flow-dependent characteristics in polymer-platelet-aggregate formation, platelet binding and string formation for all mutants. The phenotypes observed under flow conditions were not related to the mutated VWF domain. By MD simulations we further investigated how VWD 2A/IID mutations might alter the ability of VWF to form carboxy-terminal dimers. In conclusion, our study offers a comprehensive picture of shear-dependent and shear-independent dysfunction of VWD type 2A mutants. Furthermore, our microfluidic assay might open new possibilities for diagnosis of new VWD phenotypes and treatment choice for VWD patients with shear-dependent VWF dysfunctions that are currently not detectable by static tests.</description><subject>Biological and medical sciences</subject><subject>Blood Coagulation, Fibrinolysis and Cellular Haemostasis</subject><subject>Blood coagulation. Blood cells</subject><subject>Blood Platelets - physiology</subject><subject>Dimerization</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>HEK293 Cells</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Microfluidics</subject><subject>Molecular and cellular biology</subject><subject>Molecular Dynamics Simulation</subject><subject>Mutation - genetics</subject><subject>Phenotype</subject><subject>Platelet diseases and coagulopathies</subject><subject>Protein Structure, Tertiary - genetics</subject><subject>Shear Strength - physiology</subject><subject>von Willebrand Disease, Type 2 - classification</subject><subject>von Willebrand Disease, Type 2 - genetics</subject><subject>von Willebrand Factor - genetics</subject><subject>von Willebrand Factor - metabolism</subject><issn>0340-6245</issn><issn>2567-689X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0M9LwzAUB_AgipvTm2fJxZOrJs2PNt7GnFoYeJnoraTJK-3oj5F0wsA_3pZNBfGS5D0-5PG-CF1SckupJHerZ8oCSgOiSHiExqGQUSBj9X6MxoRxEsiQixE6835NCJVciVM06lsqjnk4Rp8fbYPfyqqCzOnGYlt60B5wt9sADmd4U0DTDoXHSTKf9scDHlySLO7xDFu9w2WDuwJwVeaA2xz7ArQLfOfAe7C43na66fCfMbk2XevO0UmuKw8Xh3uCXh8Xq_lzsHx5SuazZWB4yLpAasok4yoSMoskDSFjyhrBRUasNQysIowZbo0SKieEk1xEYZwpFVHFFAc2QdP9v8a13jvI040ra-12KSXpEGI6hNi_0iHEnl_t-Wab1WB_8HdqPbg-AO2NrvJ-JVP6XxeLKJIR793N3nVFCTWk63brmn7R_8d-AYCEhWw</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Brehm, Maria A.</creator><creator>Huck, Volker</creator><creator>Aponte-Santamaría, Camilo</creator><creator>Obser, Tobias</creator><creator>Grässle, Sandra</creator><creator>Oyen, Florian</creator><creator>Budde, Ulrich</creator><creator>Schneppenheim, Sonja</creator><creator>Baldauf, Carsten</creator><creator>Gräter, Frauke</creator><creator>Schneider, Stefan W.</creator><creator>Schneppenheim, Reinhard</creator><general>Schattauer GmbH</general><general>Schattauer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2014</creationdate><title>von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor</title><author>Brehm, Maria A. ; Huck, Volker ; Aponte-Santamaría, Camilo ; Obser, Tobias ; Grässle, Sandra ; Oyen, Florian ; Budde, Ulrich ; Schneppenheim, Sonja ; Baldauf, Carsten ; Gräter, Frauke ; Schneider, Stefan W. ; Schneppenheim, Reinhard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-6a136349756b7612eb39dc545b0ddc3ed9033c4dc959f0040f5728b99719394e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Biological and medical sciences</topic><topic>Blood Coagulation, Fibrinolysis and Cellular Haemostasis</topic><topic>Blood coagulation. Blood cells</topic><topic>Blood Platelets - physiology</topic><topic>Dimerization</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>HEK293 Cells</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Microfluidics</topic><topic>Molecular and cellular biology</topic><topic>Molecular Dynamics Simulation</topic><topic>Mutation - genetics</topic><topic>Phenotype</topic><topic>Platelet diseases and coagulopathies</topic><topic>Protein Structure, Tertiary - genetics</topic><topic>Shear Strength - physiology</topic><topic>von Willebrand Disease, Type 2 - classification</topic><topic>von Willebrand Disease, Type 2 - genetics</topic><topic>von Willebrand Factor - genetics</topic><topic>von Willebrand Factor - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brehm, Maria A.</creatorcontrib><creatorcontrib>Huck, Volker</creatorcontrib><creatorcontrib>Aponte-Santamaría, Camilo</creatorcontrib><creatorcontrib>Obser, Tobias</creatorcontrib><creatorcontrib>Grässle, Sandra</creatorcontrib><creatorcontrib>Oyen, Florian</creatorcontrib><creatorcontrib>Budde, Ulrich</creatorcontrib><creatorcontrib>Schneppenheim, Sonja</creatorcontrib><creatorcontrib>Baldauf, Carsten</creatorcontrib><creatorcontrib>Gräter, Frauke</creatorcontrib><creatorcontrib>Schneider, Stefan W.</creatorcontrib><creatorcontrib>Schneppenheim, Reinhard</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brehm, Maria A.</au><au>Huck, Volker</au><au>Aponte-Santamaría, Camilo</au><au>Obser, Tobias</au><au>Grässle, Sandra</au><au>Oyen, Florian</au><au>Budde, Ulrich</au><au>Schneppenheim, Sonja</au><au>Baldauf, Carsten</au><au>Gräter, Frauke</au><au>Schneider, Stefan W.</au><au>Schneppenheim, Reinhard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor</atitle><jtitle>Thrombosis and haemostasis</jtitle><addtitle>Thromb Haemost</addtitle><date>2014</date><risdate>2014</risdate><volume>111</volume><issue>1</issue><spage>96</spage><epage>108</epage><pages>96-108</pages><issn>0340-6245</issn><eissn>2567-689X</eissn><coden>THHADQ</coden><abstract>Summary The bleeding disorder von Willebrand disease (VWD) is caused by mutations of von Willebrand factor (VWF), a multimeric glycoprotein essential for platelet-dependent primary haemostasis. VWD type 2A–associated mutations each disrupt VWF biosynthesis and function at different stages, depending on the VWF domain altered by the mutation. These effects cause considerable heterogeneity in phenotypes and symptoms. To characterise the molecular mechanisms underlying the specific VWF deficiencies in VWD 2A/IIC, IID and IIE, we investigated VWF variants with patient-derived mutations either in the VWF pro-peptide or in domains D3 or CK. Additionally to static assays and molecular dynamics (MD) simulations we used microfluidic approaches to perform a detailed investigation of the shear-dependent function of VWD 2A mutants. For each group, we found distinct characteristics in their intracellular localisation visualising specific defects in biosynthesis which are correlated to respective multimer patterns. Using microfluidic assays we further determined shear flow-dependent characteristics in polymer-platelet-aggregate formation, platelet binding and string formation for all mutants. The phenotypes observed under flow conditions were not related to the mutated VWF domain. By MD simulations we further investigated how VWD 2A/IID mutations might alter the ability of VWF to form carboxy-terminal dimers. In conclusion, our study offers a comprehensive picture of shear-dependent and shear-independent dysfunction of VWD type 2A mutants. Furthermore, our microfluidic assay might open new possibilities for diagnosis of new VWD phenotypes and treatment choice for VWD patients with shear-dependent VWF dysfunctions that are currently not detectable by static tests.</abstract><cop>Stuttgart</cop><pub>Schattauer GmbH</pub><pmid>24598842</pmid><doi>10.1160/TH13-11-0902</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0340-6245
ispartof Thrombosis and haemostasis, 2014, Vol.111 (1), p.96-108
issn 0340-6245
2567-689X
language eng
recordid cdi_crossref_primary_10_1160_TH13_11_0902
source MEDLINE; Thieme Connect Journals
subjects Biological and medical sciences
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Blood coagulation. Blood cells
Blood Platelets - physiology
Dimerization
Fundamental and applied biological sciences. Psychology
HEK293 Cells
Hematologic and hematopoietic diseases
Humans
Medical sciences
Microfluidics
Molecular and cellular biology
Molecular Dynamics Simulation
Mutation - genetics
Phenotype
Platelet diseases and coagulopathies
Protein Structure, Tertiary - genetics
Shear Strength - physiology
von Willebrand Disease, Type 2 - classification
von Willebrand Disease, Type 2 - genetics
von Willebrand Factor - genetics
von Willebrand Factor - metabolism
title von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T11%3A31%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=von%20Willebrand%20disease%20type%202A%20phenotypes%20IIC,%20IID%20and%20IIE:%20A%20day%20in%20the%20life%20of%20shear-stressed%20mutant%20von%20Willebrand%20factor&rft.jtitle=Thrombosis%20and%20haemostasis&rft.au=Brehm,%20Maria%20A.&rft.date=2014&rft.volume=111&rft.issue=1&rft.spage=96&rft.epage=108&rft.pages=96-108&rft.issn=0340-6245&rft.eissn=2567-689X&rft.coden=THHADQ&rft_id=info:doi/10.1160/TH13-11-0902&rft_dat=%3Cpubmed_cross%3E24598842%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/24598842&rfr_iscdi=true